TECO 2030 ASA (TECO.OL)
NOK 0.55
(0.0%)
NOK 0.55
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 5.65 Million | 11.33 Million | 12.12 Million | 1.96 Million | - |
| Cost of Revenue | 13.73 Million | 73.76 Million | 55.47 Million | 15.77 Million | - |
| Gross Profit | -8.07 Million | -62.42 Million | -43.35 Million | -13.8 Million | - |
| Operating Expenses | 96.74 Million | 20.76 Million | 9.62 Million | 12.97 Million | 2.63 Million |
| Selling, General and Administrative Expenses | 48.55 Million | 20.76 Million | 9.62 Million | 11.87 Million | 2.63 Million |
| Research and Development Expenses | 3.2 Million | 2.12 Million | 2.02 Million | 1.1 Million | - |
| Other Expenses | 44.98 Million | - | - | - | - |
| Cost and Expenses | 110.47 Million | 94.53 Million | 65.09 Million | 28.75 Million | 2.63 Million |
| Operating Income | -101.13 Million | -83.19 Million | -52.97 Million | -26.78 Million | -2.63 Million |
| Interest Expense | 19.5 Million | 9.01 Million | 2.18 Million | 172.94 Thousand | - |
| Income Tax Expense | - | - | 76.96 Thousand | 7439.00 | -10.54 Million |
| Earnings before Tax | -117.66 Million | -93.08 Million | -52.91 Million | -27.22 Million | -2.62 Million |
| Net Income | -117.66 Million | -93.08 Million | -52.99 Million | -27.22 Million | -2.62 Million |
| Earnings Per Share Basic | -0.73 | -0.65 | -0.42 | -0.56 | -0.02 |
| Earnings Per Share Diluted | -0.73 | -0.65 | -0.42 | -0.56 | -0.02 |
| Weighted Average Shares Outstanding | 160.54 Million | 143.7 Million | 126.5 Million | 48.21 Million | 125 Million |
| Weighted Average Shares Outstanding (Diluted) | 160.54 Million | 143.7 Million | 126.5 Million | 48.21 Million | 125 Million |
| Gross Margin | -1.43 | -5.51 | -3.58 | -7.01 | - |
| EBIT Margin | -14.99 | -6.20 | -3.77 | -13.17 | - |
| Profit Margin | -20.81 | -8.21 | -4.37 | -13.83 | - |
| EBITDA | -84.78 Million | -71.15 Million | -43.43 Million | -26.14 Million | - |
| Earnings Before Tax Margin | -17.88 | -7.34 | -4.37 | -13.61 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 396.95 Thousand | 396.95 Thousand | 5.65 Million | -3.23 Million | 824 Thousand | 1.12 Million |
| Cost of Revenue | 2.54 Million | 2.54 Million | 90.53 Million | 7.49 Million | 17.88 Million | 10.17 Million |
| Gross Profit | -2.15 Million | -2.15 Million | -84.87 Million | -10.72 Million | -17.05 Million | -9.05 Million |
| Operating Expenses | 20.72 Million | 20.72 Million | 19.94 Million | 23.22 Million | 6.17 Million | 12.48 Million |
| Selling, General and Administrative Expenses | 12.72 Million | 12.72 Million | - | 17.72 Million | 6.17 Million | 12.48 Million |
| Research and Development Expenses | - | - | - | 3.2 Million | - | 1.1 Million |
| Other Expenses | 8 Million | 8 Million | - | 23.22 Million | - | - |
| Cost and Expenses | 23.27 Million | 23.27 Million | 110.47 Million | 30.71 Million | 24.05 Million | 22.66 Million |
| Operating Income | -22.87 Million | -22.87 Million | -104.81 Million | -31.55 Million | -23.23 Million | -21.54 Million |
| Interest Expense | - | - | 18.92 Million | - | - | - |
| Income Tax Expense | - | - | 4.00 | - | - | 3.00 |
| Earnings before Tax | -58.66 Million | -58.66 Million | -117.66 Million | -39 Million | -22.2 Million | -28.94 Million |
| Net Income | -58.66 Million | -58.66 Million | -117.66 Million | -39 Million | -22.2 Million | -28.94 Million |
| Earnings Per Share Basic | -0.36 | -0.36 | - | -0.24 | -0.14 | -0.18 |
| Earnings Per Share Diluted | -0.36 | -0.36 | - | -0.24 | -0.14 | -0.18 |
| Weighted Average Shares Outstanding | 162.95 Million | 162.95 Million | 160.54 Million | 160.54 Million | 160.39 Million | 160.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 162.95 Million | 162.95 Million | 160.54 Million | 160.54 Million | 160.39 Million | 160.39 Million |
| Gross Margin | -5.42 | -5.42 | -15.01 | 3.32 | -20.70 | -8.06 |
| EBIT Margin | -49.89 | -49.89 | - | 8.59 | -24.10 | -16.38 |
| Profit Margin | -147.79 | -147.79 | -20.81 | 12.06 | -26.95 | -25.77 |
| EBITDA | -19.8 Million | -19.8 Million | - | -27.78 Million | -19.86 Million | -18.4 Million |
| Earnings Before Tax Margin | -57.63 | -57.63 | -18.54 | 9.75 | -28.20 | -19.18 |
MTEN
TAR
1432
JPAVF
FFARMS
CVE